Corbus Pharmaceuticals Holdings, Inc. Prepaid Expense, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Prepaid Expense, Current of $1.09 million as of 2021-12-31, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2022-08-09
- 2021-12-31: Prepaid Expense, Current $1.09M.
- 2018-12-31: Prepaid Expense, Current $2.49M.
- 2018-09-30: Prepaid Expense, Current $2.80M.
- 2018-06-30: Prepaid Expense, Current $2.88M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2021-12-31 | $1.09M 10-Q · filed 2022-08-09 |
| 2018-12-31 | $2.49M 10-K · filed 2019-03-12 |
| 2018-09-30 | $2.80M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.88M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.53M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.81M 10-K · filed 2019-03-12 |
| 2017-03-31 | $1.07M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $930.26K 10-Q · filed 2017-05-09 |
| 2016-09-30 | $315.80K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $274.92K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $474.56K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $376.51K 10-K · filed 2017-03-08 |
| 2015-09-30 | $98.38K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $249.14K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $210.75K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $270.56K 10-K · filed 2016-03-28 |
| 2014-09-30 | $20.05K 10-Q · filed 2014-11-13 |
| 2013-12-31 | $2.50K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |